Stay updated on Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous v3.2.0. This change appears to be a site version/update note and does not modify study details or user-facing content.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding lapse notice that warned of possible delays and unprocessed submissions. The page now lacks the operating-status disclaimer directing users to cc.nih.gov and opm.gov.SummaryDifference0.3%

- Check42 days agoChange DetectedThe new page appears to reflect layout tweaks and small text edits without altering the study design or key criteria, and no changes to primary outcomes or enrollment figures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference4%

- Check78 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.